|
|
|
By Irwin Hirsh, Q-Specialists AB | A method of defining role boundaries for knowledge workers in the IT industry maps nicely to CMC process development for biologics and pharmaceutical manufacturing. |
|
|
|
By Jeffrey C. Baker, Ph.D. | A set of tools NASA developed assessing new, rapidly developed and deployed technology could help biopharmas adopt advanced tech post-commercialization. |
|
|
|
| Taking Charge Of Your Stability Program | White Paper | By P. Hamill, Ph.D., A. Glekas, Ph.D., and G. Pirozzi, Ph.D., MilliporeSigma | Conducting stability studies is a critical aspect of the drug development process. Learn how consolidating stability testing with a single partner offers improved efficiency, reduced risk, and more. |
|
|
|
|
|
|
|
|
|
|
|
